Samrat Remedies Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24231MH2003PLC392453 Incorporated 21 August 2003 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Revenue · FY 2023
₹12.76 Cr
▲ 1862% YoY
Net profit · FY 2023
₹8.77 Cr
Net margin 68.8%
EBITDA · FY 2023
₹11.05 Cr
EBITDA margin 86.6%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.07 Cr
Issued & subscribed
Satisfied charges
₹8.91 Cr
No open charges
Company age
23 yrs
Est. 2003
Employees · EPFO
7
Provident fund records

About Samrat Remedies Limited

Data last updated:

Samrat Remedies Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 August 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2003PLC392453.

The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.07 Cr. It is led by directors including Hitesh Champak Parekh (Managing Director) and Champaklal Kantilal Parekh (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 208 2nd Floor De Elmas Pahadi Village Sonawala Cross Lane No. 2 Goregaon East, Mumbai, Maharashtra, India – 400063.

As per the financials filed for FY 2023, the company reported a revenue of ₹12.76 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.77 Cr (net margin 68.8%) and EBITDA of ₹11.05 Cr (EBITDA margin 86.6%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 27% over five years.

The company has about 7 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Samrat Remedies. As per MCA filings, the company has satisfied charges of ₹8.91 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹2.89 Cr; the latest was in June 2023. Its 4 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Chemtech Finechem Private Limited with revenue of ₹71.87 Lakh. The company has 2 MSME Form 1 returns on record for the period ending Sep 2020, listing 25 overdue payments to 6 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website samratremedies.com.

Company details

CIN U24231MH2003PLC392453
Registration Number 392453
Incorporation Date 21 August 2003
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Samrat Remedies has one previous CIN (Corporate Identification Number): U24231GJ2003PLC042774. The current CIN is U24231MH2003PLC392453, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231MH2003PLC392453Current
U24231GJ2003PLC042774Previous

Contact details

Samrat Remedies Limited's registered office is in Mumbai, Maharashtra. Its website is samratremedies.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    208 2nd Floor De Elmas Pahadi Village Sonawala Cross Lane No. 2 Goregaon East, Mumbai, Maharashtra, India – 400063
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Samrat Remedies Limited, buy the company report.

Comprehensive company report
Samrat Remedies Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Samrat Remedies operates one associated brand: Samrat Remedies. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and exports fine chemicals and pharmaceutical intermediates globally.samratremedies.com

Financials of Samrat Remedies Limited

FY 2024 filings available

Samrat Remedies Limited reported revenue of ₹12.76 Cr (up 1862% YoY) for FY 2023.

Revenue · FY 2023
₹12.76 Cr ▲ 1862%
Net profit · FY 2023
₹8.77 Cr margin 68.8%
EBITDA · FY 2023
₹11.05 Cr margin 86.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 47%
5 years · compounded
▼ 27%
EBITDA CAGR growth
5 years · compounded
▲ 39%

Revenue has declined at a compounded annual rate (CAGR) of 27% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹12.76 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.05 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8.77 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin86.6%
Net Profit Margin68.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Samrat Remedies Limited, buy the company report.

Board of directors of Samrat Remedies Limited

Samrat Remedies has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Champaklal Kantilal ParekhWhole-Time Director25 Aug 200323 Years 2 MonthsCurrent
Hitesh Champak ParekhManaging Director25 Aug 200323 Years 2 MonthsCurrent
Saroj Champaklal ParekhWhole-Time Director16 Sep 200521 Years 2 MonthsCurrent
Sangeeta Hitesh ParekhWhole-Time Director16 Sep 200521 Years 2 MonthsCurrent

Peer comparison

Samrat Remedies Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Samrat Remedies Limitedthis company₹12.76 Cr (FY 2023)₹8.77 Cr68.8%1862.0%7Mumbai, Maharashtra, India
Chemtech Finechem Private Limited₹71.87 Lakh (FY 2025)-73.0%Vadodara, Gujarat, India
Hatri Pharma Private Limited₹71.68 Lakh (FY 2025)-93.0%Hyderabad, Telangana, India
Syngenesis Chemscience Private Limited₹66.12 Lakh (FY 2025)-20.0%Nashik, Maharashtra, India
Ascentus Organics Private Limited₹63.59 Lakh (FY 2025)32.0%Sinnar, Maharashtra, India

To see the full peer comparison of Samrat Remedies Limited, buy the company report.

Auditor

Samrat Remedies Limited is audited by NALIN S PAREKH & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
NALIN S PAREKH & COFY 2023106842W

Shareholding

The shareholding of Samrat Remedies Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Samrat Remedies Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹8.91 Cr
Breakdown by lending institutions
The Saraswat Co-Operative Bank Limited₹5.31 Cr
Others₹3.60 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Aug 200810133784Others₹3.6 CrSatisfied
30 Jan 200810102043The Saraswat Co-Operative Bank Limited₹55.5 LakhSatisfied
15 Apr 200610004406The Saraswat Co-Operative Bank Limited₹1.5 CrSatisfied
15 Apr 200680017200The Saraswat Co-Operative Bank Limited₹3.25 CrSatisfied

To see the full charge records of Samrat Remedies Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Samrat Remedies Limited has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹2.89 Cr; the latest was in June 2023.

Total deals
11
Secondary share transfers
6
Funding rounds
5
Disclosed funding
₹2.89 Cr

Deals on record (5 of 11)

WhenDealAmountParties
Jun 2023Secondary share transferUndisclosedBuyer: an individual
Seller: Riza Company Limited
Aug 2020Secondary share transferUndisclosedBuyer: an individual
Seller: Central Chemical INC
Sep 2007Secondary share transferUndisclosedBuyer: Hitesh Champak Parekh HUF, 2 individuals
Seller: Kush Hindustan Entertainment Limited , Hema Trading Co. Private Limited, Real Gold Trading Company Private Limited
Sep 2006Funding round₹50 LakhInvestors: Javda India Impex Limited , Hema Trading Co. Private Limited, Kush Hindustan Entertainment Limited
Dec 2005Secondary share transferUndisclosedBuyer: 4 individuals
Seller: Samrat Pharmachem Limited & Champak C Parekh, Samrat Pharmachem Limited & Saroj C Parekh, Samrat Pharmachem Limited & Sangeeta Hitesh Parekh

To see the full deal history of Samrat Remedies Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Samrat Remedies Limited was last rated by Icra on 18 Jun 2015.

Rating agencyRated onRating
Icra18 Jun 2015

To see the full credit ratings and regulatory alerts of Samrat Remedies Limited, buy the company report.

MSME payment delays

Samrat Remedies Limited has 2 MSME Form 1 returns on record for the period ending Sep 2020, listing 25 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 6)

SupplierAmount dueDue sinceReported on
Jigs Chemical Limited
Eskay Iodine Private Limited
Rishabh Intermediates
Interplastica Bharat Private Limited
an individual supplier

To see the full MSME payment records of Samrat Remedies Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Samrat Remedies has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Samrat Remedies India Private LimitedU24100MH1985PTC035969

To see the full group structure of Samrat Remedies Limited, buy the company report.

Employees & EPFO

Samrat Remedies Limited has a workforce of 7 employees on its EPFO records as of Mar 2020.

Employee count
7
Employee growth
-75%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2019-207
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Samrat Remedies Limited, buy the company report.

GST

No GST registration is on our record for Samrat Remedies Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Samrat Remedies Limited has 7 board changes on record since 2003: 4 appointments and 3 cessations. The latest: Champaklal Kantilal Parekh ceased to be Director on 01 Jan 2012.

AGM
Samrat Remedies Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Samrat Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 09 Aug 2008 via Charge ID 10133784 with Others was fully satisfied on 25 Mar 2022.
Charges
A charge with Others of Rs. 3.60 Cr registered on 09 Aug 2008 with Charge ID 10133784 was modified on 23 Oct 2020.
Charges
A charge registered on 30 Jan 2008 via Charge ID 10102043 with The Saraswat Co-Operative Bank Limited was fully satisfied on 17 Jan 2018.
Charges
A charge registered on 15 Apr 2006 via Charge ID 80017200 with The Saraswat Co-Operative Bank Limited was fully satisfied on 17 Jan 2018.
Ceased
Champaklal Kantilal Parekh ceased to be Director.
Ceased
Sangeeta Hitesh Parekh ceased to be Director.
Ceased
Saroj Champaklal Parekh ceased to be Director.
Charges
A charge registered on 15 Apr 2006 via Charge ID 10004406 with The Saraswat Co-Operative Bank Limited was fully satisfied on 11 Aug 2008.
Charges
A charge with Others amounted to Rs. 3.60 Cr with Charge ID 10133784 was registered on 09 Aug 2008.
Charges
A charge with The Saraswat Co-Operative Bank Limited of Rs. 3.25 Cr registered on 15 Apr 2006 with Charge ID 80017200 was modified on 04 Mar 2008.

10 earlier events are in the company report.

Frequently asked questions

Samrat Remedies is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 August 2003 (23+ years old) and is registered under CIN U24231MH2003PLC392453.

Samrat Remedies has 4 current directors:

The latest financial statements of Samrat Remedies on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Samrat Remedies is U24231MH2003PLC392453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Samrat Remedies has 1 court case on record: 1 filed against it.

Samrat Remedies was incorporated on 21 August 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.

Samrat Remedies has 11 deals on record (6 secondary share transfers, 5 funding rounds), with disclosed funding of ₹2.89 Cr; the latest was in June 2023.

The peers of Samrat Remedies by revenue are Chemtech Finechem Private Limited, Hatri Pharma Private Limited, Syngenesis Chemscience Private Limited, Ascentus Organics Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Champaklal Kantilal Parekh ceased to be Director on 01 Jan 2012. Sangeeta Hitesh Parekh ceased to be Director on 01 Jan 2012. Saroj Champaklal Parekh ceased to be Director on 01 Jan 2012. Samrat Remedies has 7 board changes on record in total.

Samrat Remedies has 2 MSME Form 1 returns on record for the period ending Sep 2020, listing 25 overdue payments to 6 micro and small suppliers. The latest return was filed on 11 Dec 2020.

Samrat Remedies can be reached through the website samratremedies.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Samrat Remedies is at 208 2nd Floor De Elmas Pahadi Village Sonawala Cross Lane No. 2 Goregaon East, Mumbai, Maharashtra, India – 400063.